LEADER 03690nam  22006375  450 
001 9910254539703321
005 20200630080833.0
010   $a3-319-21371-7
024 7 $a10.1007/978-3-319-21371-2
035   $a(CKB)3710000000501075
035   $a(EBL)4089847
035   $a(SSID)ssj0001584944
035   $a(PQKBManifestationID)16263467
035   $a(PQKBTitleCode)TC0001584944
035   $a(PQKBWorkID)14866078
035   $a(PQKB)11791112
035   $a(DE-He213)978-3-319-21371-2
035   $a(MiAaPQ)EBC4089847
035   $a(PPN)190518928
035   $a(EXLCZ)993710000000501075
100   $a20151102d2016      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aClinical Nuclear Medicine in Pediatrics /$fedited by Luigi Mansi, Egesta Lopci, Vincenzo Cuccurullo, Arturo Chiti
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016.
215   $a1 online resource (381 p.)
300   $aDescription based upon print version of record.
311   $a3-319-21370-9 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aThe global effort towards harmonization of pediatrics imaging -- Peculiar aspects and problems of Diagnostic Nuclear Medicine in Pediatrics -- PET/MRI in children -- Current issues in molecular radiotherapy in children -- Radiation risk from medical exposure in children -- Emergency/urgency -- CNS (non-oncologic) -- Lung -- Endocrinology -- Cardiology -- Musculoskeletal -- Gastrointestinal -- Nephro-Urinary system -- Oncology -- Children Care in 2020: issues and perspectives.
330   $aThis book provides a comprehensive state-of-the-art review of pediatric nuclear medicine, encompassing both diagnostic and therapeutic applications. Detailed attention is paid to the role of FDG PET-CT within oncology, but a variety of other long-established or less frequently used diagnostic procedures are also covered. Each indication is critically discussed from a clinical perspective, with analysis of benefits and limitations and comparison against the information yield of alternative techniques. The coverage of therapy based on radiopharmaceuticals includes the most relevant current strategies, including those utilizing radioiodine, MIBG, or radiolabelled peptides. In addition, issues concerning the radiation risk of nuclear medicine procedures in children are addressed. All chapters have been written by international experts and include the most up-to-date scientific and clinical information.
606   $aNuclear medicine
606   $aPediatrics
606   $aOncology  
606   $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048
606   $aPediatrics$3https://scigraph.springernature.com/ontologies/product-market-codes/H49006
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
615  0$aNuclear medicine.
615  0$aPediatrics.
615  0$aOncology  .
615 14$aNuclear Medicine.
615 24$aPediatrics.
615 24$aOncology.
676   $a610
702   $aMansi$b Luigi$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aLopci$b Egesta$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aCuccurullo$b Vincenzo$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aChiti$b Arturo$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254539703321
996   $aClinical Nuclear Medicine in Pediatrics$92518949
997   $aUNINA